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Development of Bacterial Infections in Cancer Patients," by Michel P. Glauser and
Stephen H. Zinner. The latter chapter reviews systematically the predisposing fac-
tors which result in unusual susceptibility. The specific side effects of various
cytotoxic agents are discussed, but this section could be enlarged. These chapters
would be illuminating to any practitioner faced with treating cancer patients who
may have a bacterial infection. As Klastersky points out, it is clearly better to pre-
vent infection than to have to treat it, and his chapter, "Infection Prevention in
Cancer Patients," is another outstanding one and well worth the time investment for
a busy practitioner. Antibiotic prophylaxis, protected environments, immunopro-
phylaxis, and granulocyte replacement are all covered (although briefly) in this
chapter.
I recommend this volume to medical people who want practical information
relating to infections in cancer patients. Hematologists, infectious diseases
specialists, internists, and pediatricians could all make use of this volume. Hospital
and departmental libraries could provide it for those who need a ready reference,
while practitioners would want a copy for themselves to peruse at their convenience.
ROBERT S. BALTIMORE
Department ofPediatrics
Yale University School ofMedicine
NEUROFIBROMATOSIS. (VON RECKLINGHAUSEN DISEASE). GENETICS, CELL BIOLOGY,
AND BIOCHEMISTRY. ADVANCES IN NEUROLOGY. VOLUME 29. Edited by Vincent M.
Riccardi and John J. Mulvihill. New York, Raven Press, 1981. 282 pp. $29.50.
This eclectic collection of essays and scientific papers was assembled from a
workshop held on the hundredth anniversary of the publication of von Reck-
linghausen's monograph describing multiple neurofibromatosis. In the preface the
editors state that "neurofibromatosis seems to be a disease whose time has come,"
and many of the contributors echo this sentiment. Indeed, many of the papers are
written in the style of a research grant proposal.
The most provocative and novel papers have little direct bearing on the
pathogenesis or biology of neurofibromatosis. Rather, they present experimental
approaches which might profitably be applied to neurofibromatosis research. Thus
Weston reviews the regulation of neural crest cell development by extracellular
matrix. Greenberg and Kessler et al. show how soluble factors alter the differentia-
tion of neural crest cells in vitro. There are several papers dealing with the effect of
polypeptide growth factors on fibroblasts and neurons. Sidman reviews the use of
mouse mutants in the study of neuron-Schwann cell interactions.
There are several papers of historical interest, including a brief biography of von
Recklinghausen, a translation of several of his case reports of neurofibromatosis,
and a picture of Joseph Merrick, the individual about whom Frederick Treeves
wrote The Elephant Man. There are several contributions dealing with the clinical
features of neurofibromatosis and a chapter on problems in diagnosis. It was disap-
pointing, but not surprising, to discover that the experts at this workshop could not
agree on minimal criteria for the diagnosis ofneurofibromatosis and were unable to
resolve collectively the controversy regarding the role of nerve growth factor in the
diagnosis and pathogenesis of neurofibromatosis.
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toward understanding the genetic defect or pathological pleomorphism of neuro-
fibromatosis. While it may provide grist for the neurobiologist's mill, more casual
inquirers would do just as well reading about neurofibromatosis in a standard
medicine or neurology text.
LEONARD MILSTONE
Department ofDermatology
Yale University School ofMedicine